Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Microbot Medical Inc. entered into Engagement Letter with H.C. Wainwright & Co., LLC valued at an aggregate cash fee equal to 7.0% of the gross proceeds (effective 2023-05-16).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- H.C. Wainwright & Co., LLC
- Value
- an aggregate cash fee equal to 7.0% of the gross proceeds
- Effective
- 2023-05-16
Exact text from the filing
On May 16, 2023 and in connection with the Offering, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright agreed to serve as the exclusive placement agent for the issuance and sale of securities of the Company pursuant to the Purchase Agreement.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Microbot Medical Inc. entered into Securities Purchase Agreement with an institutional investor valued at aggregate gross proceeds from the Offering of approximately $1.4 million (effective 2023-05-22).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- an institutional investor
- Value
- aggregate gross proceeds from the Offering of approximately $1.4 million
- Effective
- 2023-05-22
Exact text from the filing
On May 22, 2023, Microbot Medical Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Offering”), an aggregate of 655,569 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), at an offering price of $2.20 per share, for aggregate gross proceeds from the Offering of approximately $1.4 million before deducting the placement agent fee (as described in greater detail below) and related offering expenses.
View on SEC.gov